Latest Publications

TIM3(+) breast cancer cells license immune evasion during micrometastasis outbreak

Talquetamab improves patient-reported symptoms and health-related quality of life in relapsed or refractory multiple myeloma: Results from the phase 1/2 MonumenTAL-1 study

Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma

Mindfulness-based stress reduction intervention during pregnancy changes maternal brain

Latest news

New research programme to tackle childhood leukaemia at the Josep Carreras Institute

July 24, 2025

New research programme to tackle childhood leukaemia at the Josep Carreras Institute

The Communication Unit of the Josep Carreras Institute is accredited as a Scientific Culture and Innovation Unit

July 23, 2025

The Communication Unit of the Josep Carreras Institute is accredited as a Scientific Culture and Innovation Unit

Epigenetics on demand to tackle inflammatory diseases

July 17, 2025

Epigenetics on demand to tackle inflammatory diseases

A new cell therapy for leukaemia shows high efficacy and safety in the laboratory

July 07, 2025

A new cell therapy for leukaemia shows high efficacy and safety in the laboratory

A new drug developed in Spain shows great potential against Rett Syndrome

June 26, 2025

A new drug developed in Spain shows great potential against Rett Syndrome

Dr. Mar Mallo: We recommend the use of Optical Genome Mapping in the diagnosis of leukaemia

June 25, 2025

Dr. Mar Mallo: We recommend the use of Optical Genome Mapping in the diagnosis of leukaemia

The Innomed Awards highlight fifteen innovative biomedical projects in their second edition

June 20, 2025

The Innomed Awards highlight fifteen innovative biomedical projects in their second edition

Locations

IJC Josep Trueta

Who we are, in data

428

4 programs

39 Research Groups

371 Researchers and technicians

57 Management staff

272 Women

155 Men

1 Others